Søgning på udtrykket 'covid' giver 97 resultater


Dokumenter [11] Sider [2] Kalender [26] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Udarbejdet i samarbejde mellem DSOG og Dansk Infektionsmedicinsk Selskab

Invitation til møde den 20. maj 2022

I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sotrovimab anbefales ikke længere til behandling af tidlig COVID-19 med Omicron BA.2

Sider [2]

…andling ved HIV og hepatitis B og C, HIV behandling af gravide, HIV post exposure profylakse (PEP), Pre-exposure profylakse mod HIV (PrEP), Borrelia: Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klaringsrapport, COVID-19: Marie Helleberg/Jens Lundgren, Lothar Wiese, Michael Dalager-Pedersen, Merete Storgaard, Isik Somuncu Johansen og Gitte Kronborg COVID-19 retningslinje, Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende c…


Kalender [26]

21. marts, Aarhus Universitetshospital, Skejby
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
6.07.2022
. Introduction. COVID-19 is commonly experienced as an acute illness, yet some people continue to have symptoms that persist for weeks, or months (commonly referred to as ‘long-COVID’). It remains unclear which patients are at highest risk of developing long-COVID. In this protocol, we describe plans to develop a prediction model to identify individuals at risk of developing long-COVID. . Methods and analysis. We will use the national Early Pandemic Evaluation and Enhanced Surveillance of C…
BMJ Open
6.07.2022
. Objectives. Evaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute viral respiratory illness (AVRI) due to COVID-19. . Design. Retrospective cohort. . Setting. The USA; 2017–2018 influenza season, 2018–2019 influenza season, and 2019–2020 influenza/COVID-19 season. . Participants. People with hypertension (HTN) taking an ACEi, ARB or other HTN medications, and experiencing AVRI. . M…
PLoS One Infectious Diseases
6.07.2022
by Steve Van den Bulck, Jonas Crèvecoeur, Bert Aertgeerts, Nicolas Delvaux, Thomas Neyens, Gijs Van Pottelbergh, Patrick Coursier, Bert Vaes. Introduction The Covid-19 pandemic had a tremendous impact on healthcare but uncertainty remains about the extent to which primary care provision was affected. Therefore, this paper aims to assess the impact on primary care provision and the evolution of the incidence of disease during the first year of the Covid-19 pandemic in Flanders (Belgium). Methods Care prov…
PLoS One Infectious Diseases
6.07.2022
…ine Dieter, Letícia de Almeida Brondani, Cristiane Bauermann Leitão, Fernando Gerchman, Natália Emerim Lemos, Daisy Crispim. . Although advanced age and presence of comorbidities significantly impact the variation observed in the clinical symptoms of COVID-19, it has been suggested that genetic variants may also be involved in the disease. Thus, the aim of this study was to perform a systematic review with meta-analysis of the literature to identify genetic polymorphisms that are likely to contribute t…
Lancet Infectious Diseases
6.07.2022
A credit to clinical research volunteers, the global community is blessed with a panoply of pharmaceutical agents to mitigate COVID-19 in this third year of the SARS-CoV-2 pandemic. Multiple vaccines and therapeutic interventions with small molecule antivirals (ritonavir-boosted nirmatrelvir1 and remdesivir2) and macromolecular anti-spike neutralising monoclonal antibodies3–5 have reached the front lines of the war against COVID-19. The deluge of cutting-edge basic, translational, and clinical knowledge a…
Lancet Infectious Diseases
6.07.2022
CAS + IMD is not authorised in any US region as of Jan 24, 2022, because data show that CAS + IMD is not active against omicron-lineage variants. In this study, done before the emergence of omicron-lineage variants, a single subcutaneous 1200 mg dose of CAS + IMD protected against COVID-19 for up to 5 months of community exposure to susceptible strains of SARS-CoV-2 in the pre-exposure prophylaxis setting, in addition to the post-exposure prophylaxis setting that was previously shown.
International Journal of Infectious Diseases
6.07.2022
Infection with SARS-CoV-2 usually causes mild to moderate respiratory disease. However, elderly patients and those with underlying chronic medical conditions are at high risk of progressing to severe COVID-19 (Ko et al., 2021, Thakur et al., 2021).
BMJ Open
5.07.2022
. Lane S, Yeomans A, Shakir S. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature. BMJ Open 2022;12:e059223. doi: 10.1136/bmjopen-2021-059223. This article was previously published with an error. The authors have been made aware of an error in table 7 against row 20 (Lai, reference 61), for the percentage of carditis cases who had received a second vaccine dose. Th…
PLoS One Infectious Diseases
5.07.2022
by Kirill Chmel, Aigul Klimova, Nikita Savin.
PLoS One Infectious Diseases
5.07.2022
by Hasan Selcuk Ozger, Resul Karakus, Elif Nazli Kuscu, Umit Emin Bagriacik, Nihan Oruklu, Melek Yaman, Melda Turkoglu, Gonca Erbas, Aysegul Yucel Atak, Esin Senol.
Journal of the American Medical Association
5.07.2022
The FDA has authorized the first nonprescription diagnostic test that can identify multiple viruses that cause COVID-19–like respiratory symptoms, including respiratory syncytial virus (RSV). FDA officials see it as another step toward diagnostic testing at home for certain viruses.
Journal of the American Medical Association
5.07.2022
Expiration dates on several monoclonal antibody therapies for COVID-19 were extended by the FDA and the US Department of Health and Human Services’ Assistant Secretary for Preparedness and Response (ASPR) as a way to preserve supplies of the drugs for future outbreaks.
Journal of the American Medical Association
5.07.2022
This Viewpoint discusses how relying almost exclusively on health care systems to address overall health in the US is problematic, noting that safety net programs and other social policies can serve as powerful population-level interventions that can affect long-standing health disparities.
Journal of the American Medical Association
5.07.2022
This modeling study estimates the excess deaths attributable to COVID-19 disease in Massachusetts during the Delta (June to December 2021) and Omicron (December 2021 to February 2022) waves.
International Journal of Infectious Diseases
5.07.2022
Abbreviations: AKI, acute kidney disease; CKD, chronic kidney disease; GFR, glomerular filtration rate; SpO2, oxygen saturation.
BMJ Open
4.07.2022
. Objective. To explore the impact of the COVID-19 on the distribution, type and patterns of diseases in hospitalised children under local antiepidemic measures. . Design. Retrospective chart review. . Setting. Electronic medical records of patients hospitalised in the paediatric department of a tertiary hospital in South China from 21 January 2019 to 20 January 2021. . Participants. Records of 2139 patients. . Outcome measures. Data were analysed before and during the COVID-19 pandemic. Disea…
Clinical Microbiology and Infection
4.07.2022
The adenovirus-based vaccine Gam-COVID-Vac (Sputnik V), showed promising effectiveness in a phase 3 clinical trial; however, data concerning its impact at a population level are scarce. The Republic of San Marino (RSM) conducted a SARS-CoV-2 vaccination program mainly based (>80%) on Gam-COVID-Vac. Our aims were to investigate the impact of Gam-COVID-Vac vaccination program and its effectiveness in a retrospective observational study based on the entire RSM population aged 12 or older.
Infection
4.07.2022
. Abstract. The emergence of COVID-19 has caused a significant impact on healthcare workers (HCWs) across the globe. A few of these challenges include high workload, lack of coordination and direction, changing information, shortage of personal protective equipment (PPE), managing isolation, fear, and increased anxiety, adapting to changes in healthcare practice and policy, coping strategies, and emotional and physical needs. Here, we shed light on some aspects of these…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
7.07.2022
COVID-19 vaccination can cause a host of both acute and delayed dermatologic reactions, say Indian researchers, who urge a thorough assessment in every affected patient to demonstrate causality. .
Medscape Infectious Diseases
6.07.2022
A Connecticut patient with lymphoma had COVID-19 for at least 471 days, and the virus appeared to evolve into several new lineages. .
Medscape Infectious Diseases
6.07.2022
A new combination vaccine for COVID-19 will likely be coming out this fall, offering more protection against the Omicron variants of COVID-19. .
Medscape Infectious Diseases
5.07.2022
The federal government is planning for a potential rise in COVID-19 cases this fall and is setting aside $3.2 billion for 105 million doses of Pfizer's vaccine. .
Medscape Infectious Diseases
5.07.2022
"They object on religious grounds to all available COVID-19 vaccines because they were developed using cell lines derived from aborted children." .
Medscape Infectious Diseases
5.07.2022
The available COVID-19 vaccines entail different levels of risk for skin reactions. Women and young people are most likely to have these reactions. .
Medscape Infectious Diseases
30.06.2022
The court's action follows a decision in December in which the justices declined an emergency request to halt the requirement that does not offer an exemption for religious beliefs. .
Medscape Infectious Diseases
30.06.2022
The virus is evolving faster than vaccines are being developed. But a booster in the fall with the adapted vaccine could benefit people who do not have a high level of antibodies, said one expert. .
Morbidity and Mortality Weekly Report (MMWR)
30.06.2022
This report describes COVID-19 vaccine provider availability and vaccination coverage among children aged 5-11.
Medscape Infectious Diseases
30.06.2022
Immunity against new Omicron variants is getting weaker and weaker. Is another vaccination with the available vaccines worth it? .
ECDC COVID-19 updates
30.06.2022
This weekly report provides an overview of the epidemiological situation of the COVID-19 pandemic and COVID-19 vaccine rollout by country. 
Statens Serum Institut
30.06.2022
Antallet af nye covid-19-tilfælde steg med 27% i uge 25. Samtidig ses der en stabilisering i koncentrationen af SARS-CoV-2 i spildevandet. Det viser den seneste tendensrapport fra Statens Serum Institut.
Eurosurveillance latest updates
30.06.2022
As the COVID-19 pandemic began in early 2020, primary care influenza sentinel surveillance networks within the Influenza - Monitoring Vaccine Effectiveness in Europe (I-MOVE) consortium rapidly adapted to COVID-19 surveillance. This study maps system adaptations and lessons learned about aligning influenza and COVID-19 surveillance following ECDC / WHO/Europe recommendations and preparing for other diseases possibly emerging in the future. Using a qualitative approach, we describe the adaptations …
Medscape Infectious Diseases
29.06.2022
"I'm bummed to know that I might forever just get infected," said the 31-year-old singer, who is vaccinated and boosted. .
Medscape Infectious Diseases
29.06.2022
To answer some of those questions, infectious disease experts shared what they know during a media briefing today sponsored by the Infectious Diseases Society of America. .
Medscape Infectious Diseases
29.06.2022
The FDA's advisers on vaccines deliberated Tuesday on what direction the agency should give drugmakers about future modifications to their COVID shots to address changes in the virus. .

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,468 s

Cookies og privatliv